Diclofenac etalhyaluronate
As of the edition of 20 October 2026, Diclofenac etalhyaluronate is a drug: marketed, first approved in 2021 (JP); acts on PTGER2.
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 2021
- Kind
- Unknown
- Brand name
- Joyclu
- First approved
- 23 March 2021 (JP)
- Approvals on record
- 2 in 1 region
- Holder of the most recent approval
- Seikagaku
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Target
| Gene | Protein | UniProt |
|---|---|---|
| PTGER2 | Prostaglandin E2 receptor EP2 subtype | P43116 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| Seikagaku | Applicant | 2021 to now |